Sunekos 200

Sunekos

Aesthetic / Skin‑booster Injectable

Dermal biostimulator (HA + amino acids)

Class III CE‑marked medical device. :contentReference[oaicite:30]{index=30}

Class III CE‑marked medical device. :contentReference[oaicite:30]{index=30}

Dermal biostimulator (HA + amino acids)

Description

Sunekos 200 is an injectable skin‑booster that uses a patented formula combining low‑molecular-weight hyaluronic acid (HA) and a specific mix of six amino acids (HY6AA). It stimulates fibroblasts to produce new collagen and elastin, promoting regeneration of the extracellular matrix (ECM) to restore skin elasticity, hydration, firmness, and natural volume loss. :contentReference[oaicite:1]{index=1}

Bnefits

Stimulates dermal extracellular matrix regeneration — collagen and elastin synthesis. :contentReference[oaicite:2]{index=2}
Improves skin elasticity, firmness, and overall skin quality. :contentReference[oaicite:3]{index=3}
Enhances skin hydration and moisture retention due to hyaluronic acid. :contentReference[oaicite:4]{index=4}
Reduces fine lines and wrinkles, improves skin tone and radiance. :contentReference[oaicite:5]{index=5}
Restores volume loss and dermal density (bio‑volumetric effect) without volumizing filler. :contentReference[oaicite:6]{index=6}

Indications

Mild to moderate skin laxity or early skin ageing (fine lines, superficial wrinkles). :contentReference[oaicite:7]{index=7}
Dehydrated, dull skin needing improved hydration and elasticity. :contentReference[oaicite:8]{index=8}
Loss of skin tone, early signs of photo‑ageing, solar elastosis. :contentReference[oaicite:9]{index=9}
Areas such as face (including periocular), neck, décolleté, hands (and other areas as professionally indicated). :contentReference[oaicite:10]{index=10}
Prevention of skin ageing / elastosis and maintenance of skin health. :contentReference[oaicite:11]{index=11}

Composition

Low‑molecular-weight hyaluronic acid (sodium hyaluronate, sterile, apyrogenous). :contentReference[oaicite:12]{index=12}
Amino‑acid complex HY6AA: Glycine, L‑Proline, L‑Lysine HCP, L‑Valine, L‑Alanine, (and L‑Leucine per some sources). :contentReference[oaicite:13]{index=13}

Formulation

Injectable two‑part system: sterile vials containing HA solution + vials with lyophilised amino‑acid powder to be reconstituted prior to injection. :contentReference[oaicite:14]{index=14}
Non‑crosslinked HA + amino‑acid blend, intended for intradermal injection by trained medical professionals. :contentReference[oaicite:15]{index=15}

Packaging

Package containing 2 × 3 ml HA vials + 2 amino‑acid bottles (as per many supplier listings). :contentReference[oaicite:16]{index=16}

Usage

To be administered only by licensed medical professionals / trained aesthetic practitioners. :contentReference[oaicite:17]{index=17}
Inject intradermally using fine needle, following recommended injection technique and intervals (standard facial protocol: 4 injections). :contentReference[oaicite:18]{index=18}
Typical treatment involves a series of injections spaced 7–10 days apart. :contentReference[oaicite:19]{index=19}

Contraindications

Known hypersensitivity to hyaluronic acid or any component of the formulation. :contentReference[oaicite:22]{index=22}
Active skin inflammation, infection or compromised skin integrity at treatment site. :contentReference[oaicite:23]{index=23}
Not to be used by non‑professionals; only by qualified medical personnel (due to Class III medical device status). :contentReference[oaicite:24]{index=24}

Adverse Effects

Transient redness, swelling, bruising or tenderness at injection site (common to injectables). :contentReference[oaicite:25]{index=25}
Possible localized nodules or irregularities if not properly administered. :contentReference[oaicite:26]{index=26}
Risk of allergic reaction in individuals sensitive to components. :contentReference[oaicite:27]{index=27}

Storage Conditions

Store according to manufacturer instructions — keep sterile until use; do not freeze; protect from contamination. :contentReference[oaicite:28]{index=28}
Use immediately after reconstitution; do not reuse vials. :contentReference[oaicite:29]{index=29}

Duration

Initial course: ~4 sessions over 3\u20134 weeks (per standard protocol). :contentReference[oaicite:20]{index=20}

Onset

Some improvements often visible after the first session; full effects progressively over weeks, with optimal result ~2\u20136 months. :contentReference[oaicite:21]{index=21}